3R4-34163-43883

3 vaccinations 9 coded responses 28 check-ins 9 free-text entries 3 call cases

Sex: Female
Age at first dose: 46-50
ZIP prefix: 454 / OH
Registered: 2021-01-28

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-27
Dose 1 — Pfizer-BioNTech
2021-01-28
Registered in v-safe
2021-01-28
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Hypoaesthesia, Paraesthesia — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Free text: Facial tingling/numbness and dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-29
Survey response — days 1–6 daily, dose 1
MedDRA: Hypoaesthesia — Feeling: Fair · Headache, Fatigue or tiredness

Free text: Facial numbness and tingling

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-30
Survey response — days 1–6 daily, dose 1
MedDRA: Hypoaesthesia — Feeling: Good · Fatigue or tiredness

Free text: Facial numbness occurs off & on.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-01
Survey response — days 1–6 daily, dose 1
MedDRA: Hypoaesthesia — Feeling: Good · Fatigue or tiredness

Free text: Facial numbness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-03
Health check-in — day 7, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-10
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-02-17
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-02-18
Dose 2 — Pfizer-BioNTech
2021-02-18
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-02-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Fatigue or tiredness

Adult check-in
2021-02-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-22
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains, Muscle or body aches

Adult check-in
2021-02-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-02-25
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-04
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-11
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-03-18
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-03-25
Survey response — day 35, dose 2
MedDRA: Impaired healing, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Ongoing stomach wound healing problem. Almost healed, then reopened. · Healthcare visit (other): Wound clinic

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Report sent to call center — day 35, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-01
Survey response — day 42, dose 2
MedDRA: Pain, Swelling, Uterine haemorrhage — Feeling: Fair

Free text: Pain, swelling, and heavy bleeding due to uterine tumor.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-21
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-28
Dose 3 — Pfizer-BioNTech
2021-10-01
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-10-02
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-10-09
Survey response — day 42, dose 3
MedDRA: Breast cancer, Tumour pain, Uterine neoplasm — Feeling: Fair

Free text: Have breast cancer and possible uterine cancer, extreme pain due to uterine tumor.

MedDRA releases: 2024-11 · check-in free text available
2021-11-27
Survey response — 3 months, dose 3
MedDRA: Cough, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Extreme sinus infection with non stop coughing.

MedDRA releases: 2024-11 · check-in free text available
2021-11-27
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-29
Call 2 — Left Voicemail
2022-08-29
Survey response — 12 months, dose 3
MedDRA: Leiomyoma, Office visit, Squamous cell carcinoma of the cervix — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Non malignant squamous cells on cervix. Leiomyoma has increased in size & is inoperable/high risk. · Healthcare visit (other): Doctors in office appt.

MedDRA releases: 2024-11 · check-in free text available
2022-08-29
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2022-08-30
Call 1 — Left Voicemail
2022-08-30
Call 1 — Left Voicemail
2022-08-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-27	Pfizer-BioNTech
2	2021-02-18	Pfizer-BioNTech
3	2021-08-28	Pfizer-BioNTech	No

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-01-28

Systemic reaction (other): Facial tingling/numbness and dizziness

2021-01-29

Systemic reaction (other): Facial numbness and tingling

2021-01-30

Systemic reaction (other): Facial numbness occurs off & on.

2021-02-01

Systemic reaction (other): Facial numbness

Release 6 — day 35, dose 2

2021-03-25

Symptoms: Ongoing stomach wound healing problem. Almost healed, then reopened.

Healthcare visit (other): Wound clinic

Release 6 — day 42, dose 2

2021-04-01

Symptoms: Pain, swelling, and heavy bleeding due to uterine tumor.

Release 10 — day 42, dose 3

2021-10-09

Symptoms: Have breast cancer and possible uterine cancer, extreme pain due to uterine tumor.

Release 10 — 3 months, dose 3

2021-11-27

Symptoms: Extreme sinus infection with non stop coughing.

Release 12 — 12 months, dose 3

2022-08-29

Symptoms: Non malignant squamous cells on cervix. Leiomyoma has increased in size & is inoperable/high risk.

Healthcare visit (other): Doctors in office appt.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	Breast cancer	·	·	✓
SD	Cough	·	·	✓
SD	Impaired healing	✓	✓	✓
SD	Leiomyoma	·	·	✓
SD	Pain	✓	✓	✓
SD	Sinusitis	·	·	✓
SD	Squamous cell carcinoma of the cervix	·	·	✓
SD	Swelling	✓	✓	✓
SD	Tumour pain	·	·	✓
SD	Uterine haemorrhage	✓	✓	✓
SD	Uterine neoplasm	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Hypoaesthesia	✓	✓	✓
SRO	Paraesthesia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release